Kyle W. Gano
Overview
Kyle W. Gano received an average of $4M in total compensation, including $411K in salary, at Neurocrine Biosciences from 2016 to 2020.
2020Neurocrine BiosciencesChief Development and Strategy Officer
2019Neurocrine BiosciencesChief Development and Strategy Officer
2018Neurocrine BiosciencesChief Business Development Officer
2017Neurocrine BiosciencesChief Business Development Officer
2016Neurocrine BiosciencesChief Business Development Officer
Source: SEC filings on April 9, 2021 and April 17, 2019.
Related executives
We found eight more executives who work or worked at Neurocrine Biosciences.
Kevin Gorman
Neurocrine Biosciences
Chief Executive Officer
Jude Onyia
Neurocrine Biosciences
Chief Scientific Officer
Eiry Roberts
Neurocrine Biosciences
Chief Medical Officer
Matthew Abernethy
Neurocrine Biosciences
Chief Financial Officer
Eric Benevich
Neurocrine Biosciences
Chief Commercial Officer
Haig Bozigian
Neurocrine Biosciences
Chief Development Officer
Timothy Coughlin
Neurocrine Biosciences
Chief Financial Officer
Christopher O'Brien
Neurocrine Biosciences